Corcept Therapeutics Incorporated (CORT)
Total asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 482,375 | 401,858 | 365,978 | 353,874 | 306,486 |
Total assets | US$ in thousands | 621,517 | 583,430 | 423,756 | 571,731 | 412,312 |
Total asset turnover | 0.78 | 0.69 | 0.86 | 0.62 | 0.74 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $482,375K ÷ $621,517K
= 0.78
Corcept Therapeutics Inc's total asset turnover has fluctuated over the past five years. The ratio was lowest in 2020 at 0.62, indicating that the company generated $0.62 in revenue for every dollar of assets it held that year. In contrast, the ratio was highest in 2021 at 0.86, suggesting an improvement in the company's efficiency in utilizing its assets to generate sales.
However, the ratio decreased in 2022 to 0.69 before slightly increasing to 0.78 in 2023. This fluctuation may imply inconsistencies in the company's ability to efficiently generate revenue from its assets over the years.
Overall, Corcept Therapeutics Inc's total asset turnover indicates the company's effectiveness in utilizing its assets to generate sales revenue. It is essential for the company to consistently monitor and optimize this ratio to ensure efficient asset utilization and improve overall financial performance.
Peer comparison
Dec 31, 2023